The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COMMON STOCK | 901384107 | 13,361,764 | 2,497,526 | SH | SOLE | 2,497,526 | 0 | 0 | ||
4D Molecular Therapeutics, Inc. | COM | 35104E100 | 3,186,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
AbCellera Biologics Inc. | COM | 00288U106 | 124,691,149 | 27,525,640 | SH | SOLE | 27,525,640 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 792,566,676 | 42,864,612 | SH | SOLE | 42,864,612 | 0 | 0 | ||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 1,510,969 | 1,208,775 | SH | SOLE | 1,208,775 | 0 | 0 | ||
Acrivon Therapeutics, Inc. | COMMON STOCK | 004890109 | 378,128 | 52,885 | SH | SOLE | 52,885 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 17,043,495 | 10,787,022 | SH | SOLE | 10,787,022 | 0 | 0 | ||
Aerovate Therapeutics, Inc. | COM | 008064107 | 49,692,888 | 1,680,517 | SH | SOLE | 1,680,517 | 0 | 0 | ||
Akero Therapeutics, Inc. | COM | 00973Y108 | 68,535,558 | 2,713,205 | SH | SOLE | 2,713,205 | 0 | 0 | ||
Aligos Therapeutics, Inc. | COM | 01626L105 | 2,034,872 | 2,076,400 | SH | SOLE | 2,076,400 | 0 | 0 | ||
Alpine Immune Sciences, Inc. | COM | 02083G100 | 3,233,752 | 81,578 | SH | SOLE | 81,578 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 59,536,370 | 151,215 | SH | SOLE | 151,215 | 0 | 0 | ||
Athira Pharma, Inc. | COM | 04746L104 | 8,641,431 | 3,153,807 | SH | SOLE | 3,153,807 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,652,869,802 | 10,568,897 | SH | SOLE | 10,568,897 | 0 | 0 | ||
Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | 123,076,293 | 4,942,823 | SH | SOLE | 4,942,823 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 51,440,974 | 10,126,176 | SH | SOLE | 10,126,176 | 0 | 0 | ||
Biomea Fusion, Inc. | COM | 09077A106 | 31,528,788 | 2,108,949 | SH | SOLE | 2,108,949 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 227,427 | 13,331 | SH | SOLE | 13,331 | 0 | 0 | ||
Celcuity Inc. | COM | 15102K100 | 33,533,525 | 1,552,478 | SH | SOLE | 1,552,478 | 0 | 0 | ||
Celldex Therapeutics, Inc. | COM | 15117B202 | 10,393,619 | 247,644 | SH | SOLE | 247,644 | 0 | 0 | ||
Century Therapeutics, Inc. | COM | 15673T100 | 3,333,383 | 797,460 | SH | SOLE | 797,460 | 0 | 0 | ||
Cerevel Therapeutics Holdings, Inc. | COM | 15678U128 | 67,632,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 36,812,171 | 19,477,339 | SH | SOLE | 19,477,339 | 0 | 0 | ||
Compass Therapeutics, Inc. | COM | 20454B104 | 3,084,107 | 1,557,630 | SH | SOLE | 1,557,630 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 10,947,545 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Denali Therapeutics Inc. | COM | 24823R105 | 76,574,381 | 3,731,695 | SH | SOLE | 3,731,695 | 0 | 0 | ||
Design Therapeutics, Inc. | COM | 25056L103 | 6,698,344 | 1,662,120 | SH | SOLE | 1,662,120 | 0 | 0 | ||
Dyne Therapeutics, Inc. | COM | 26818M108 | 8,091,150 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 106,522,676 | 5,840,059 | SH | SOLE | 5,840,059 | 0 | 0 | ||
Enliven Therapeutics, Inc. | COM | 29337E102 | 2,019,912 | 114,833 | SH | SOLE | 114,833 | 0 | 0 | ||
Entrada Therapeutics, Inc. | COM | 29384C108 | 68,948,655 | 4,865,819 | SH | SOLE | 4,865,819 | 0 | 0 | ||
Fate Therapeutics, Inc. | COM | 31189P102 | 13,345,449 | 1,818,181 | SH | SOLE | 1,818,181 | 0 | 0 | ||
Foghorn Therapeutics Inc. | COM | 344174107 | 302,131 | 45,027 | SH | SOLE | 45,027 | 0 | 0 | ||
Generation Bio Co. | COM | 37148K100 | 1,510,861 | 371,219 | SH | SOLE | 371,219 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 5,787,244 | 8,128,151 | SH | SOLE | 8,128,151 | 0 | 0 | ||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 46,605,957 | 1,062,123 | SH | SOLE | 1,062,123 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 39,452,307 | 4,088,322 | SH | SOLE | 4,088,322 | 0 | 0 | ||
Immatics N.V. | SHS | N44445109 | 67,720,113 | 6,443,398 | SH | SOLE | 6,443,398 | 0 | 0 | ||
Immunocore Holdings plc | ADS | 45258D105 | 98,495,670 | 1,515,318 | SH | SOLE | 1,515,318 | 0 | 0 | ||
Immunovant, Inc. | COM | 45258J102 | 13,732,041 | 425,009 | SH | SOLE | 425,009 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,061,155,515 | 36,179,665 | SH | SOLE | 36,179,665 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 9,305,590 | 343,000 | SH | SOLE | 343,000 | 0 | 0 | ||
KALA BIO, Inc. | COM | 483119202 | 2,124,906 | 266,613 | SH | SOLE | 266,613 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 55,432,954 | 2,809,577 | SH | SOLE | 2,809,577 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 91,053,177 | 17,310,490 | SH | SOLE | 17,310,490 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 30,236,357 | 169,934 | SH | SOLE | 169,934 | 0 | 0 | ||
Kymera Therapeutics, Inc. | COM | 501575104 | 241,036,306 | 5,995,928 | SH | SOLE | 5,995,928 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K200 | 3,117,986 | 1,172,175 | SH | SOLE | 1,172,175 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 526,014,858 | 1,969,798 | SH | SOLE | 1,969,798 | 0 | 0 | ||
Mersana Therapeutics, Inc. | COM | 59045L106 | 4,865,795 | 1,086,115 | SH | SOLE | 1,086,115 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 4,784,757 | 190,476 | SH | SOLE | 190,476 | 0 | 0 | ||
Monte Rosa Therapeutics, Inc. | COM | 61225M102 | 34,658,470 | 4,916,095 | SH | SOLE | 4,916,095 | 0 | 0 | ||
Mural Oncology plc | ORD SHS | G63365103 | 1,088,040 | 222,503 | SH | SOLE | 222,503 | 0 | 0 | ||
Neumora Therapeutics, Inc. | COM | 640979100 | 8,715,451 | 633,851 | SH | SOLE | 633,851 | 0 | 0 | ||
Neurogene Inc. | COM | 64135M105 | 23,211,164 | 456,015 | SH | SOLE | 456,015 | 0 | 0 | ||
NewAmsterdam Pharma Company N.V. | ORDINARY SHARES | N62509109 | 2,289,959 | 96,827 | SH | SOLE | 96,827 | 0 | 0 | ||
Nurix Therapeutics, Inc. | COM | 67080M103 | 57,067,238 | 3,882,125 | SH | SOLE | 3,882,125 | 0 | 0 | ||
Opthea Limited | SPONSORED ADS | 68386J208 | 8,950,865 | 2,177,826 | SH | SOLE | 2,177,826 | 0 | 0 | ||
Perspective Therapeutics, Inc. | COM | 46489V104 | 178,247 | 149,787 | SH | SOLE | 149,787 | 0 | 0 | ||
Pfizer Inc. | COM | 717081103 | 971,250 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
PMV Pharmaceuticals, Inc. | COM | 69353Y103 | 547,441 | 322,024 | SH | SOLE | 322,024 | 0 | 0 | ||
Praxis Precision Medicines, Inc. | COM | 74006W207 | 8,026,144 | 131,533 | SH | SOLE | 131,533 | 0 | 0 | ||
Prelude Therapeutics Inc. | COM | 74065P101 | 47,986,926 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | ||
Prime Medicine, Inc. | COM | 74168J101 | 7,199,262 | 1,028,466 | SH | SOLE | 1,028,466 | 0 | 0 | ||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 800,681 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | ||
Relay Therapeutics, Inc. | COM | 75943R102 | 9,628,971 | 1,160,117 | SH | SOLE | 1,160,117 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 77,985,395 | 9,545,336 | SH | SOLE | 9,545,336 | 0 | 0 | ||
Revolution Medicines, Inc. | COM | 76155X100 | 243,312,295 | 7,549,249 | SH | SOLE | 7,549,249 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 277,241,155 | 6,398,365 | SH | SOLE | 6,398,365 | 0 | 0 | ||
Roivant Sciences Ltd. | SHS | G76279101 | 78,141,810 | 7,413,834 | SH | SOLE | 7,413,834 | 0 | 0 | ||
Sage Therapeutics, Inc. | COM | 78667J108 | 7,631,247 | 407,217 | SH | SOLE | 407,217 | 0 | 0 | ||
Sagimet Biosciences Inc. | COM SER A | 786700104 | 7,489,887 | 1,381,898 | SH | SOLE | 1,381,898 | 0 | 0 | ||
Sana Biotechnology, Inc. | COM | 799566104 | 23,809,490 | 2,380,949 | SH | SOLE | 2,380,949 | 0 | 0 | ||
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 49,453,031 | 5,434,399 | SH | SOLE | 5,434,399 | 0 | 0 | ||
Stoke Therapeutics, Inc. | COM | 86150R107 | 45,473,981 | 3,368,443 | SH | SOLE | 3,368,443 | 0 | 0 | ||
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 25,167 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | ||
Talis Biomedical Corporation | COM | 87424L207 | 4,447,826 | 508,323 | SH | SOLE | 508,323 | 0 | 0 | ||
Tango Therapeutics, Inc. | COM | 87583X109 | 5,955,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
Taysha Gene Therapies, Inc. | COM SHS | 877619106 | 11,493,650 | 4,004,756 | SH | SOLE | 4,004,756 | 0 | 0 | ||
TScan Therapeutics, Inc. | COM | 89854M101 | 22,111,248 | 2,784,792 | SH | SOLE | 2,784,792 | 0 | 0 | ||
Tyra Biosciences, Inc. | COM | 90240B106 | 173,955 | 10,607 | SH | SOLE | 10,607 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 68,473,079 | 1,466,547 | SH | SOLE | 1,466,547 | 0 | 0 | ||
Vaxcyte, Inc. | COM | 92243G108 | 3,339,334 | 48,885 | SH | SOLE | 48,885 | 0 | 0 | ||
Verve Therapeutics, Inc. | COM | 92539P101 | 22,463,518 | 1,691,530 | SH | SOLE | 1,691,530 | 0 | 0 | ||
vTv Therapeutics, Inc. | CL A | 918385204 | 2,289,798 | 97,314 | SH | SOLE | 97,314 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 12,070,388 | 545,431 | SH | SOLE | 545,431 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 42,777,881 | 993,679 | SH | SOLE | 993,679 | 0 | 0 |